Sequential combination of high dose methotrexate andl-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm-Reference-Cited by-同舟云学术

Sequential combination of high dose methotrexate andl-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm

Published:2012-03-16 Issue:8 Volume:53 Page:1633-1637
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gilis Lila,Lebras Laure,Bouafia-Sauvy Fadhela,Espinouse Daniel,Felman Pascale,Berger Francoise,Salles Gilles,Coiffier Bertrand,Michallet Anne-Sophie

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.656627

Reference20 articles.

1. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma

2. Identification of a leukemic counterpart of the plasmacytoid dendritic cells

3. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms

4. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects

5. CD4+ CD56+ Cutaneous Neoplasms: A Distinct Hematological Entity?

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Lymphomas;Rook's Textbook of Dermatology;2024-03-19

2. Pregnancy and Acute Lymphoblastic Leukemia: A Case Series and Review of Literature;Indian Journal of Medical and Paediatric Oncology;2023-05-17

3. Conventional Therapeutics in BPDCN Patients—Do They Still Have a Place in the Era of Targeted Therapies?;Cancers;2022-08-02

4. Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN);Expert Opinion on Pharmacotherapy;2022-01-21

5. A Current View on Pathogenesis, Diagnosis, and Treatment of Some Rare Acute Leukemia Variants;Clinical oncohematology;2022